Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

Bo Gao; Amanda Russell; Jonathan Beesley; Xiao Qing Chen; Sue Healey; Michelle Henderson; Mark Wong; Catherine Emmanuel; Laura Galletta; Sharon E Johnatty; David Bowtell; Michelle Haber; Murray Norris; Paul Harnett; Georgia Chenevix-Trench; Rosemary L Balleine; Anna deFazio

Journal article

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

Bo Gao, Amanda Russell, Jonathan Beesley, Xiao Qing Chen, Sue Healey, Michelle Henderson, Mark Wong, Catherine Emmanuel, Laura Galletta, Sharon E Johnatty, David Bowtell, Michelle Haber, Murray Norris, Paul Harnett, Georgia Chenevix-Trench, Rosemary L Balleine, Anna deFazio

Scientific Reports | NATURE PUBLISHING GROUP | Published : 2014

DOI: 10.1038/srep04669

University of Melbourne Researchers

Izhak Haviv Author Clinical Pathology

Danny Rischin Author Medicine - St Vincent's Hospital

Paul Waring Author Clinical Pathology

Robert Rome Author Obstetrics and Gynaecology Royal Women's Hospital/Mercy

Stephen Lade Author Clinical Pathology

Related Projects (2)

Australian Ovarian Cancer Study (Aocs): A Multidisciplinary Ovarian Cancer Resource For The Genomics Era

Ovarian cancer is relatively uncommon and is histologically very diverse, making it difficult to analyse ovarian cancer at a molecular level..

Molecular Epidemiology Of Ovarian Cancer: The Australian Ovarian Cancer Study National Clinical Follow-Up Core

Ovarian cancer is the seventh most common cancer in Australian women and fifth most common cause of cancer death, with approximately 1200 ne..

Grants

Awarded by Cancer Institute New South Wales and Cancer Australia

Awarded by U.S. Army Medical Research and Materiel Command

Awarded by NHMRC

Funding Acknowledgements

This project was supported by the National Health and Medical Research Council (NHMRC) of Australia (scholarship to B.G.), Cancer Institute New South Wales and Cancer Australia (552481). AdeF is funded by the University of Sydney Cancer Research Fund and the Cancer Institute NSW through the Sydney-West Translational Cancer Research Centre.We gratefully acknowledge the cooperation of the institutions that supported the study. We also acknowledge the contribution of Australian Ovarian Cancer Study Group (full list can be found at http://www.aocstudy.org), all study nurses and research assistants and would like to thank all of the women who participated in AOCS. AOCS was supported by U.S. Army Medical Research and Materiel Command DAMD17-01-1-0729, NHMRC Enabling Grant 400413 and Project Grant 400281, the Cancer Council Tasmania and the Cancer Foundation of Western Australia.